ash 2019: the lyra study update | dr. robert rifkin
Published 4 years ago • 159 plays • Length 1:37
Download video MP4
Download video MP3
Similar videos
-
0:50
robert rifkin, md, facp, tells us about the outcomes of the lyra study presented at ash 2019
-
2:55
ash 2019: the optimum trial | dr. martin kaiser
-
3:23
ash 2019: melflufen dex — horizon trial update | dr. agne paner
-
1:36
clinical trial: insight with robert rifkin, md, rocky mountain center
-
3:11
ash 2019: 3d tumor modeling — mcri update | dr. cesar rodriguez
-
2:24
ash 2019: the candor trial (late breaking abstract) | dr. saad usmani
-
3:10
ash 2019: the save trial — early detection of amyloidosis | dr. ray comenzo
-
2:01
ash 2019: 80% of patients mrd negative! (newly diagnosed) — dara krd results | dr. ola landgren
-
3:15
ash 2019: bcma car-t, immunotherapy and developing a myeloma cure | dr. siddhartha ganguly
-
2:09
dr robert rifkin outlines recent treatment advances in multiple myeloma
-
2:01
ash 2019: high-risk smoldering myeloma treatment research | dr. irene ghobrial
-
10:19
ash 2019 mpn updates-novel therapeutic targets
-
2:16
amrita krishnan, md on the best myeloma maintenance approach after transplant — imw 2019
-
1:03
robert rifkin, md, talks about what clinical data could change the way multiple myeloma is treated
-
0:32
robert rifkin, md, facp, on the role of daratumumab as maintenance therapy in the management of mm
-
1:48
dr robert rifkin discusses barriers, biomarkers in multiple myeloma
-
6:54
dr. field's major clinical accomplishment
-
0:34
robert rifkin, md, facp, regarding the role of proteasome inhibitors in maintenance therapy for mm
Clip.africa.com - Privacy-policy